PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis
出版年份 2020 全文链接
标题
PPI‐amoxicillin dual therapy for
Helicobacter pylori
infection: An update based on a systematic review and meta‐analysis
作者
关键词
-
出版物
HELICOBACTER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-21
DOI
10.1111/hel.12692
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment
- (2019) Xue Yang et al. MEDICINE
- A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
- (2019) Wei-Chen Tai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
- (2019) Jing Yang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics
- (2019) Carlo A. Fallone et al. GASTROENTEROLOGY
- High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial
- (2019) Lou Yu et al. HELICOBACTER
- Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection
- (2018) M. Zamani et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals
- (2018) Wai K. Leung et al. GASTROENTEROLOGY
- Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
- (2018) Wen Zhong Liu et al. HELICOBACTER
- Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
- (2018) Il Ju Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI
- (2018) David Y. Graham et al. HELICOBACTER
- Efficacy of High-Dose Dual Therapy Versus Bismuthcontaining Quadruple Therapy for First-Line Treatment of Helicobacter Pylori Infection and an Interim Report of Multi-Center, Randomized Control Study
- (2017) Chi-Tan Hu et al. GASTROENTEROLOGY
- Helicobacter pylori management in ASEAN: The Bangkok consensus report
- (2017) Varocha Mahachai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Optimized high-dose amoxicillin–proton-pump inhibitor dual therapies fail to achieve high cure rates in China
- (2017) Dian-Chun Fang et al. Saudi Journal of Gastroenterology
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Efficacy and safety of high-dose dual therapy forHelicobacter pylorirescue therapy: A systematic review and meta-analysis
- (2016) Cai Ping Gao et al. Journal of Digestive Diseases
- High Dose Ilaprazole/Amoxicillin as First-Line Regimen forHelicobacter pyloriInfection in Korea
- (2016) WonGun Kwack et al. Gastroenterology Research and Practice
- High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
- (2015) Jyh-Chin Yang et al. Clinical Gastroenterology and Hepatology
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
- (2015) Hirotoshi Echizen CLINICAL PHARMACOKINETICS
- Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
- (2014) Ralph-Steven Wedemeyer et al. DRUG SAFETY
- Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea
- (2011) Seung Young Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH
- (2008) Julia Kirchheiner et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search